$185.382,00
10% de descuento pagando con Transferencia
Ver más detalles
Descripcion
Indice
Autores
Muestra
Ficha Técnica
Descripción

In this issue of Hematology/Oncology Clinics, guest editors Drs. Sophie Lanzkron and Jane Little bring their considerable expertise to the topic of Sickle Cell Syndromes. Top experts in the field cover key topics such as structural racism and impact on sickle cell disease (SCD); pathophysiology and biomarkers of SCD; genetic modifiers of SCD; allogeneic transplant and gene therapy: reproductive health; chronic pain; and more.

  • Contains 16 relevant, practice-oriented topics including innovative therapies, addressing challenging complications, novel science on mechanisms of disease; preventing cognitive decline in people with SCD; quality of life in SCD; and more. 

  • Provides in-depth clinical reviews on sickle cell syndromes, offering actionable insights for clinical practice. 

  • Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews. 

1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. xii 7. Preface - p. xiii 8. Structural Racism and Impact on Sickle Cell Disease: Sickle Cell Lives Matter - p. 1063 9. Sickle Cell Disease Pathophysiology and Related Molecular and Biophysical Biomarkers - p. 1077 10. Genetic Modifiers of Sickle Cell Disease - p. 1097 11. Economics of Sickle Cell Disease and Evidence to Support Comprehensive Care - p. 1125 12. Quality of Life in Sickle Cell Disease: What Matters - p. 1137 13. Chronic Pain: Prevalence and Management - p. 1151 14. The Development of Neuroimaging Biomarkers for Cognitive Decline in Sickle Cell Disease - p. 1167 15. Clinical Vignettes Part I - p. 1187 16. Clinical Vignettes, Part II: Eyes, Teeth, and Bone - p. 1201 17. The Cardiopulmonary Complications of Sickle Cell Disease - p. 1217 18. Sickle Cell Disease and the Kidney: Filters Gone Awry - p. 1239 19. Go the Distance: Reproductive Health Care for People with Sickle Cell Disease - p. 1255 20. Genotyping and the Future of Transfusion in Sickle Cell Disease - p. 1271 21. The Evolving Landscape of Drug Therapies for Sickle Cell Disease - p. 1285 22. Allogeneic Transplant and Gene Therapy: Evolving Toward a Cure - p. 1313

Descripcion
Descripción

In this issue of Hematology/Oncology Clinics, guest editors Drs. Sophie Lanzkron and Jane Little bring their considerable expertise to the topic of Sickle Cell Syndromes. Top experts in the field cover key topics such as structural racism and impact on sickle cell disease (SCD); pathophysiology and biomarkers of SCD; genetic modifiers of SCD; allogeneic transplant and gene therapy: reproductive health; chronic pain; and more.

  • Contains 16 relevant, practice-oriented topics including innovative therapies, addressing challenging complications, novel science on mechanisms of disease; preventing cognitive decline in people with SCD; quality of life in SCD; and more. 

  • Provides in-depth clinical reviews on sickle cell syndromes, offering actionable insights for clinical practice. 

  • Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews. 

1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. xii 7. Preface - p. xiii 8. Structural Racism and Impact on Sickle Cell Disease: Sickle Cell Lives Matter - p. 1063 9. Sickle Cell Disease Pathophysiology and Related Molecular and Biophysical Biomarkers - p. 1077 10. Genetic Modifiers of Sickle Cell Disease - p. 1097 11. Economics of Sickle Cell Disease and Evidence to Support Comprehensive Care - p. 1125 12. Quality of Life in Sickle Cell Disease: What Matters - p. 1137 13. Chronic Pain: Prevalence and Management - p. 1151 14. The Development of Neuroimaging Biomarkers for Cognitive Decline in Sickle Cell Disease - p. 1167 15. Clinical Vignettes Part I - p. 1187 16. Clinical Vignettes, Part II: Eyes, Teeth, and Bone - p. 1201 17. The Cardiopulmonary Complications of Sickle Cell Disease - p. 1217 18. Sickle Cell Disease and the Kidney: Filters Gone Awry - p. 1239 19. Go the Distance: Reproductive Health Care for People with Sickle Cell Disease - p. 1255 20. Genotyping and the Future of Transfusion in Sickle Cell Disease - p. 1271 21. The Evolving Landscape of Drug Therapies for Sickle Cell Disease - p. 1285 22. Allogeneic Transplant and Gene Therapy: Evolving Toward a Cure - p. 1313

Indice
Autores
Muestra
Ficha Técnica